Key challenges in cost-effectiveness analyses of emerging MASLD therapies: adherence, adverse events, cardiometabolic benefits, and age-related uncertainty: Correspondence to editorial on “Evaluating treatment response thresholds for cost-effective treatm Eileen L. Yoon, Jeong-Yeon Cho, Mimi Kim, Huiyul Park, Hye-Lin Kim, Dae Won Jun Clinical and Molecular Hepatology.2026; 32(3): e365. CrossRef
Background/Aims Previous studies have identified a substantial degree of agreement between the non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) populations, but the same notion may not apply to normal-weight patients with a lower cardiometabolic risk burden. This study aims to investigate the cardiometabolic risk factor (CMRF) distributions between normal-weight and overweight/obese MASLD, the agreement between historical NAFLD and MASLD, and to compare the risk of liver-related events (LREs) and all-cause mortality in normal-weight versus overweight or obese MASLD.
Methods This study included participants with steatotic liver disease (SLD) from five cohorts in China (Hong Kong), South Korea, and the United States. Participants were recruited from settings including both hospitals and communities. Individuals were classified into normal-weight and overweight/obese groups.
Results This study included 33,793 participants with SLD from five cohorts, of whom 20,893 and 20,701 patients met the diagnosis of NAFLD and MASLD, respectively. Normal-weight patients with NAFLD demonstrated a lower CMRF distribution compared to those with overweight/obese NAFLD. In the community-based cohorts, the proportions with 0 CMRF ranged from 9.0 to 26.7% among normal-weight NAFLD patients, representing the discrepancy between MASLD and NAFLD definitions. Compared with the overweight/obese MASLD, the normalweight MASLD had increased all-cause mortality (normal-weight vs. overweight/obese, 23.44 and 13.80 per 1,000 person-years; P<0.001) but not LREs (2.81 and 2.59 per 1,000 person-years; P=0.54) in the Hong Kong Clinical Data Analysis and Reporting System cohort.
Conclusions Normal-weight individuals with NAFLD demonstrated a lower distribution of CMRFs, resulting in the incomplete agreement between historical NAFLD and MASLD.
Citations
Citations to this article as recorded by
Challenges in defining MASLD in lean individuals: the impact of the Fatty Liver Index on phenotypic characterisation Sherlot Juan Song, Yiwei Liu, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip Gut.2026; : gutjnl-2026-338216. CrossRef
Beyond BMI: Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria Ru‐Tao Lin, Ren‐Qiang Zeng, Xu‐Ting Shen, Qin‐Mei Sun, Xin Xin, Jia‐Mei Chen, Yi‐Yang Hu, Qin Feng Diabetes, Obesity and Metabolism.2026; 28(8): 6699. CrossRef
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression Ludovico Abenavoli, Anna Giulia Loricchio, Ivo Lopez, Domenico Morano, Abdulrahman Ismaiel, Dan Lucian Dumitrascu, Francesco Luzza Medicina.2026; 62(5): 986. CrossRef
Estimated Body Fat Percentage and Triglyceride‐Glucose Index for Identifying MASLD in Lean Asian Adults: A Cross‐Sectional Analysis Xiang‐Ran Kong, Ya‐Li Chen, Rui Li, Lu‐Xiang Shang, Sha Sha The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
MASLD and its lean phenotype Kateřina Janstová, Denisa Kyselová, Pavel Trunečka Vnitřní lékařství.2026; 72(4): 232. CrossRef
Cardiovascular and hepatic outcomes: prognostic differences across MASLD-MetALD-ALD continuum Han Ah Lee, Gi-Ae Kim, Won Kim Clinical and Molecular Hepatology.2026; 32(Suppl): e2026.0367. CrossRef
Advancing metabolic risk profiling in chronic hepatitis B: Reply to correspondence on “Metabolic health in antiviral era of chronic hepatitis B” Shang-Chin Huang, Jia-Horng Kao Clinical and Molecular Hepatology.2026; 32(1): e117. CrossRef
Correspondence to editorial 1 on “Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues” Rui Huang, Mindie H. Nguyen Clinical and Molecular Hepatology.2026; 32(1): e83. CrossRef
Steatosis paradox: Unraveling pathways of suppressive effect of hepatic steatosis on hepatitis B virus Shang-Chin Huang, Jia-Horng Kao Biomedical Journal.2026; 49(3): 100969. CrossRef
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe? Shang-Chin Huang, Tai-Chung Tseng Gut and Liver.2026; 20(3): 350. CrossRef
Insulin Resistance and Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients Under Antiviral Therapy Dong Hyun Sinn, Kyung-Ah Kim, Jung Il Lee, Geum-Youn Gwak Journal of Korean Medical Science.2026;[Epub] CrossRef
Chronic viral hepatitis with concurrent metabolic dysfunction-associated steatotic liver disease: dual etiology challenges Shang-Chin Huang, Yi-Fen Shih, Chun-Jen Liu Clinical and Molecular Hepatology.2026; 32(Suppl): e2026.0387. CrossRef
Backgrounds/Aims Transmembrane 6 superfamily member 2 (TM6SF2) E167K variant is closely associated with the occurrence and development of metabolic dysfunction-associated steatotic liver disease (MASLD). However, the role and mechanism of TM6SF2 E167K variant during MASLD progression are not yet fully understood.
Methods The Tm6sf2167K knock-in (KI) mice were subjected to high-fat diet (HFD). Hepatic lipid levels of Tm6sf2167K KI mice were detected by lipidomics analysis. Thin-layer chromatography (TLC) was used to measure the newly synthesized triglyceride (TG) and phosphatidylcholine (PC).
Results The TM6SF2 E167K variant significantly aggravated hepatic steatosis and injury in HFD-induced mice. Decreased polyunsaturated PC level and increased polyunsaturated TG level were found in liver tissue of HFD-induced Tm6sf2167K KI mice. Mechanistic studies demonstrated that the TM6SF2 E167K variant increased the interaction between TM6SF2 and PNPLA3, and impaired PNPLA3-mediated transfer of polyunsaturated fatty acids (PUFAs) from TG to PC. The TM6SF2 E167K variant increased the level of fatty acid-induced malondialdehyde and reactive oxygen species, and decreased fatty acid-downregulated cell membrane fluidity. Additionally, the TM6SF2 E167K variant decreased the level of hepatic PC containing C18:3, and dietary supplementation of PC containing C18:3 significantly attenuated the TM6SF2 E167K-induced hepatic steatosis and injury in HFD-fed mice.
Conclusions The TM6SF2 E167K variant could promote its interaction with PNPLA3 and inhibit PNPLA3-mediated transfer of PUFAs from TG to PC, resulting in the hepatic steatosis and injury during MASLD progression. PC containing C18:3 could act as a potential therapeutic supplement for MASLD patients carrying the TM6SF2 E167K variant.
Citations
Citations to this article as recorded by
Association of Circadian Rhythms With the Risk of Chronic Liver Disease: Findings From a Large Prospective Study Rong Yang, Can Shen, Yu Jia, Yi Yao, Yiheng Zhou, Yu Cheng, Yonglang Cheng, Rui Zeng, Zhi Wan, Qian Zhao, Dongze Li, Xiaoyang Liao Clinical and Translational Gastroenterology.2026; 17(1): e00949. CrossRef
High-protein diets and metabolic dysfunction-associated steatotic liver disease: A double-edged sword in liver health Hong-Yuan Yin, Qian-Hui You, Wei-Jie Zhang, Guang Ji, Yan-Qi Dang World Journal of Gastroenterology.2026;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models Jack Leslie, Kishore A. Krishnamurthy, Indresh K. Gopalsamy, Patricia Inacio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca Nature Reviews Gastroenterology & Hepatology.2026; 23(4): 286. CrossRef
1-O-acetylbritannilactone alleviates high-fat diet-induced fatty liver by covalently targeting NLRP3 Tianyang Jin, Yanni Zhao, Tingxin Xu, Yi Fang, Yaqian Cui, Wenqi Liu, Yongqiang Xiong, Jiaxi Ye, Wu Luo, Bo Hong, Guang Liang, Xiang Hu, Lijiang Huang, Yi Wang International Immunopharmacology.2026; 174: 116351. CrossRef
Using an integrative multi-omics and in vitro approach to investigate the role of tris(2-butoxyethyl) phosphate in promoting hepatic steatosis Gang Zhou, Xihan Gu, Xinyao Zhou, Shuai Chen, Hanyang Liu, Jing Wang BMJ Open Gastroenterology.2026; 13(1): e002123. CrossRef
Lipid metabolism-MAFLD crosstalk: mechanisms and therapy Bojia Li, Shengai Piao, Yin Fu, Qiang Fu, Peiyao Qin, Weitai Kong, Yidi Ma, Zhe Zhang, Xue Fang, Xiaoyang Hu Frontiers in Endocrinology.2026;[Epub] CrossRef
Current status survey and risk factor analysis of metabolic dysfunction-associated steatotic liver disease among adolescents in Hainan Province Shuo Zhou, Daya Zhang, Runyu Chen, Yan-ting Lv, Da Li, Xianfeng Huang, Fengjiao Mao, Shimei Huang, Shiju Chen, Chen Chen, Ying Mo, Yiping Du, Yuliang Huang, Fan Zeng, Qicen Yao, Feihu Bai Scientific Reports.2026;[Epub] CrossRef
Selenium Protects Against Cadmium-Induced Hepatotoxicity via Regulation of Lipid Metabolism and Inflammatory Pathways Zilong Wu, Xinyi Chen, Xiaoying Pan, Kai Luo, Zixiong Zhang, Changyu Zhou, Haibo Wang, Chuying Huang Frontiers in Bioscience-Landmark.2026;[Epub] CrossRef
Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review Aleksandra Klisic, Ratko Tomašević, Slavko Djuraskovic, Filiz Mercantepe, Ana Ninic Archives of Medical Science.2026;[Epub] CrossRef
Contemporary epidemiology of metabolic dysfunction-associated steatotic liver disease Do Han Kim, Donghyun Ko, Aijaz Ahmed, Donghee Kim Expert Review of Gastroenterology & Hepatology.2026; 20(6): 603. CrossRef
Microbial metabolites contribute to the pathogenesis of metabolic dysfunction-associated fatty liver disease in high-fat diet-fed mice Kai-Wen Cai, Zhen-Chuan Lin, Xue-Mei Zhang, Jia-Yun Yu, Tian-jiao Cui, Yi-Qing Zhang, Rong-Hua Zou, Zhi-Hua Zheng, Yao-Liang Zhou, Ting Zhu, Yong-Ping Lu Microbial Pathogenesis.2026; 218: 108634. CrossRef
Genetics and epigenetics in tumor necrosis factor-alpha (TNF-α) and transmembrane 6 superfamily member 2 (TM6SF2) in alcohol induced liver cirrhosis Bhagyalakshmi Shankarappa, Jayant Mahadevan, Pratima Murthy, Biju Viswanath, Harshad Devarbhavi, Sanjeev Jain, Meera Purushottam Frontiers in Medicine.2026;[Epub] CrossRef
Abnormal lipid metabolism in metabolic dysfunction-associated steatohepatitis (MASH) Wonseok Lee, You-Jin Choi, Hyuneui Park, Suwan Chae, Byung-Hoon Lee Toxicological Research.2026;[Epub] CrossRef
Dual effects of a high-protein diet on metabolic dysfunction-associated steatotic liver disease: Basic research on precision clinical interventions Ya-Rong Ma, Wen-Long Miao, Na Li, Gui-Zhen Zhang, Zhi-Gang Ren World Journal of Gastroenterology.2026;[Epub] CrossRef
PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD” Baokai Sun, Likun Zhuang Clinical and Molecular Hepatology.2025; 31(1): e67. CrossRef
TM6SF2 and PNPLA3: A potential dynamic duo?: Editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD” Andrea Caddeo, Rosellina M. Mancina Clinical and Molecular Hepatology.2025; 31(1): 293. CrossRef
Causal roles of immune cells and metabolites in chronic pancreatitis: a mendelian randomization study Chao Zhang, Tao Yang, Yuan Yu, Qian Jia, Wan-Meng Xiao, Sha Liu, Ze-Hui Yu, Cheng-Li Wen, Yan Wei, Hao Li, Mu-Han Lü Hereditas.2025;[Epub] CrossRef
Effects of polyphenols on non-alcoholic fatty liver disease: a case study of resveratrol Ying Zhao, Jiali Ren, Weisan Chen, Xinchen Gao, Hongjian Yu, Xiankuan Li, Yanchao Zheng, Jinlong Yang Food & Function.2025; 16(8): 2926. CrossRef
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease Mohammad Shafi Kuchay, Narendra Singh Choudhary, Bruno Ramos-Molina American Journal of Physiology-Cell Physiology.2025; 328(5): C1637. CrossRef
Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement Indrajit Bhattacharya, Deep Kumar Maity, Amit Kumar, Sampriti Sarkar, Teeshyo Bhattacharya, Amrita Sahu, Remya Sreedhar, Somasundaram Arumugam Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(10): 13647. CrossRef
Liver disease trends in the Asia-Pacific region for the next 50 years Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim Clinical and Molecular Hepatology.2025; 31(3): 671. CrossRef
Exercise-Based Interventions for Metabolic Dysfunction–Associated Fatty Liver Disease: An Umbrella Review of Systematic Reviews and Meta-Analyses Xinjuan Huang, Ruoling Yu, Manjie Guo, Xinyun Tan, Yuanqin Xia, Huihui Zou, Xuelian Liu, Chunxiang Qin Nutrition Reviews.2026; 84(7): 1418. CrossRef
The association between serum pinenes and non-alcoholic fatty liver disease based on the NHANES 2013–2014 Tuo Xiao, Xue Xing, Lulu Sun, Jin Shang Ecotoxicology and Environmental Safety.2025; 302: 118712. CrossRef
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends Salvatore Pezzino, Maria Sofia, Chiara Mazzone, Giorgia Litrico, Marcello Agosta, Gaetano La Greca, Saverio Latteri Scientific Reports.2024;[Epub] CrossRef
Metabolic dysfunction-associated fatty liver disease increases the risk of type 2 diabetes mellitus in young Korean adults Junchul Ha, Oak-Kee Hong, Kyungdo Han, Hyuk-Sang Kwon Diabetes Research and Clinical Practice.2024; 212: 111584. CrossRef
Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population Young Lee, Eun Ju Cho, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Seung-Won Oh, Jeong Yoon Yim, Goh Eun Chung Scientific Reports.2024;[Epub] CrossRef
Fatty Liver and Risk of Head and Neck Cancer in Type 2 Diabetes Mellitus: A Nationwide Cohort Study Junhee Park, Kyungdo Han, Seung Woo Lee, Yeong Jeong Jeon, Sang-Man Jin, Wonyoung Jung, Yoon Kyoung So, Sang Duk Hong, Dong Wook Shin Cancers.2023; 15(4): 1209. CrossRef
Occurrence of Liver Cancer in People without Traditional Risk Factors Junho Choi, Joohyun Park, Jae Kwang Lee, Kyunghee Cho Korean Journal of Clinical Geriatrics.2023; 24(1): 41. CrossRef
Protective effect of chlorophyll-removed ethanol extract of Lycium barbarum leaves against non-alcoholic fatty liver disease Hansol Lee, Eun Young Bae, Kyung Ah Kim, Sun Yung Ly Journal of Nutrition and Health.2023; 56(2): 123. CrossRef
Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum-Youn Gwak Scientific Reports.2023;[Epub] CrossRef
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk Keungmo Yang, Myeongjun Song Nutrients.2023; 15(18): 3970. CrossRef
Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease Da-Hye Son, Jee Hye Han, Jun-Hyuk Lee Journal of Obesity & Metabolic Syndrome.2023; 32(3): 214. CrossRef
Genome‐wide association of individual vulnerability with alcohol‐associated liver disease: A Korean genome and epidemiology study Kwang Yoon Kim, Jung Oh Kim, Young‐Sang Kim, Ja‐Eun Choi, Jae‐Min Park, Kunhee Han, Da‐Hyun Park, Yon Chul Park, Bom Taeck Kim, Kyung‐Won Hong Hepatology.2022; 75(2): 391. CrossRef
Association between serum uric acid level and non-alcoholic fatty liver disease in Koreans Huiyul Park, Kye-Yeung Park, Minki Kim, Hoon-Ki Park, Hwan-Sik Hwang Asian Biomedicine.2022; 16(1): 15. CrossRef
Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness Ji Min Choi, Hyo Eun Park, Yoo Min Han, Jooyoung Lee, Heesun Lee, Su Jin Chung, Seon Hee Lim, Jeong Yoon Yim, Goh Eun Chung Frontiers in Medicine.2022;[Epub] CrossRef
Association between non‐alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study Gi‐Ae Kim, Chi Hyuk Oh, Jung Wook Kim, Su Jin Jeong, In‐Hwan Oh, Jin San Lee, Key‐Chung Park, Jae‐Jun Shim Liver International.2022; 42(5): 1027. CrossRef
Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT Charu Arora, Anita Malhotra, Piyush Ranjan, Vishwajeet Singh, Namrata Singh, Shalimar, S. N. Dwivedi, Naval K. Vikram European Journal of Clinical Nutrition.2022; 76(9): 1332. CrossRef
Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung, Atsushi Hosui PLOS ONE.2022; 17(12): e0279242. CrossRef
Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function Ji Taek Hong, Min-Jung Lee, Sang Jun Yoon, Seok Pyo Shin, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Ki Tae Suk, Bong-Soo Kim Journal of Ginseng Research.2021; 45(2): 316. CrossRef
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik Digestive Diseases and Sciences.2021; 66(8): 2816. CrossRef
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation‐wide Cohort Study Yewan Park, Dong Hyun Sinn, Joo Hyun Oh, Myung Ji Goh, Kyunga Kim, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Geum‐Youn Gwak Hepatology.2021; 74(6): 2988. CrossRef
Relationship between Muscle Mass and Non-Alcoholic Fatty Liver Disease Jun-Hyuk Lee, Hye-Sun Lee, Byoung-Kwon Lee, Yu-Jin Kwon, Ji-Won Lee Biology.2021; 10(2): 122. CrossRef
Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou, Ilias Migdalis Journal of Diabetes Research.2021; 2021: 1. CrossRef
Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation Li Qi, Wanlin Dai, Jing Kong, Yu Tian, Yongsheng Chen Journal of Physiology and Biochemistry.2021; 77(4): 497. CrossRef
Development and initial validation of the nonalcoholic fatty liver disease self‐management questionnaire Oh Young Kwon, Yeonsoo Jang, Ji Yea Lee, Seung Up Kim, Sang Hoon Ahn Research in Nursing & Health.2021; 44(5): 844. CrossRef
Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date Małgorzata Moszak, Monika Szulińska, Marta Walczak-Gałęzewska, Paweł Bogdański International Journal of Environmental Research and Public Health.2021; 18(4): 1616. CrossRef
Dairy protein intake is inversely related to development of non-alcoholic fatty liver disease Jun-Hyuk Lee, Hye Sun Lee, Sang Bong Ahn, Yu-Jin Kwon Clinical Nutrition.2021; 40(10): 5252. CrossRef
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea Goh Eun Chung, Eun Ju Cho, Ji Won Yoon, Jeong-Ju Yoo, Young Chang, Yuri Cho, Sang-Hyun Park, Kyungdo Han, Dong Wook Shin, Su Jong Yu Metabolism.2021; 123: 154866. CrossRef
Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak European Journal of Gastroenterology & Hepatology.2021; 33(1S): e529. CrossRef
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea Jiyoon Park, Eunice Yewon Lee, Jie Li, Mi Jung Jun, Eileen Yoon, Sang Bong Ahn, Chuanli Liu, Hongli Yang, Fajuan Rui, Biyao Zou, Linda Henry, Dong Hyun Lee, Dae Won Jun, Ramsey C. Cheung, Mindie H. Nguyen Digestive Diseases.2021; 39(6): 634. CrossRef
SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE N.A. TOKTOGULOVA AVICENNA BULLETIN.2021; 23(1): 107. CrossRef
Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution Goh Eun Chung, Nam Ju Heo, Donghee Kim, Min‐Sun Kwak, Jeong Yoon Yim, Joo Sung Kim, Aijaz Ahmed Journal of Gastroenterology and Hepatology.2020; 35(1): 90. CrossRef
Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak Journal of Gastroenterology and Hepatology.2020; 35(5): 833. CrossRef
Modelling NAFLD disease burden in four Asian regions—2019‐2030 Chris Estes, Henry L. Y. Chan, Rong N. Chien, Wan‐Long Chuang, James Fung, George Boon-Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung K. Jang, Dae W. Jun, Jia H. Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace L. ‐H. Wong, Vincent Alimentary Pharmacology & Therapeutics.2020; 51(8): 801. CrossRef
Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators Seung Ha Park, Dong Joon Kim, Lindsay D. Plank European Journal of Clinical Nutrition.2020; 74(10): 1401. CrossRef
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros Metabolism.2020; 111: 154203. CrossRef
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk Eugene Han, Yong-ho Lee, Young Dae Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Kwang-Hyub Han, Hyo Suk Nam, Ji Hoe Heo, Seung Up Kim American Journal of Gastroenterology.2020; 115(4): 584. CrossRef
Neddylation of sterol regulatory element-binding protein 1c is a potential therapeutic target for nonalcoholic fatty liver treatment Uk-Il Ju, Do-Won Jeong, Jieun Seo, Jun Bum Park, Jong-Wan Park, Kyung-Suk Suh, Jae Bum Kim, Yang-Sook Chun Cell Death & Disease.2020;[Epub] CrossRef
Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Boram Park, Seong Joon An, Joo Sung Kim Journal of Korean Medical Science.2020;[Epub] CrossRef
Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population YangFan Li, Fei He, Yun He, XinTing Pan, YunLi Wu, ZhiJian Hu, Xu Lin, Xian-E Peng, ShangHua Xu BMJ Open.2020; 9(3): e026854. CrossRef
Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini Nutrients.2020; 12(6): 1819. CrossRef
The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men Hye-Kyung Chung, Ji Sun Nam, Mi-Yeon Lee, Yong-Bum Kim, Yu-Sam Won, Won-Jun Song, Young-Hwan Kim, Chul Woo Ahn, Ki-Chul Sung Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1653. CrossRef
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak International Journal of Epidemiology.2020; 49(5): 1562. CrossRef
History of Nonalcoholic Fatty Liver Disease Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad International Journal of Molecular Sciences.2020; 21(16): 5888. CrossRef
Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults Goh Eun Chung, Jiyoung Youn, Young Sun Kim, Jung Eun Lee, Sun Young Yang, Joo Hyun Lim, Ji Hyun Song, Eun Young Doo, Joo Sung Kim Nutrition.2019; 62: 32. CrossRef
Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals Hyemin Jang, Danbee Kang, Yoosoo Chang, Yeshin Kim, Jin San Lee, Ko Woon Kim, Young Kyoung Jang, Hee Jin Kim, Duk L. Na, Hee Young Shin, Mira Kang, Eliseo Guallar, Juhee Cho, Sang Won Seo Scientific Reports.2019;[Epub] CrossRef
Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee Medicine.2019; 98(6): e14139. CrossRef
Association of low skeletal muscle mass with advanced liver fibrosis in patients with non‐alcoholic fatty liver disease Min Kyu Kang, Jung Gil Park, Heon Ju Lee, Min Cheol Kim Journal of Gastroenterology and Hepatology.2019; 34(9): 1633. CrossRef
What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease? Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran Journal of Digestive Diseases.2019; 20(6): 271. CrossRef
Favorable impact of non‐alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population S.‐M. Jeong, H. Kwon, S. Park, S. J. Yu, H.‐Y. Jeong, K.‐W. Nam, H.‐M. Kwon, J.‐H. Park European Journal of Neurology.2019; 26(12): 1471. CrossRef
Association between non-alcoholic fatty liver disease and cancer incidence rate Gi-Ae Kim, Han Chu Lee, Jaewon Choe, Min-Ju Kim, Min Jung Lee, Hye-Sook Chang, In Young Bae, Hong-Kyu Kim, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim Journal of Hepatology.2018; 68(1): 140. CrossRef
Effect of longitudinal changes of body fat on the incidence and regression of nonalcoholic fatty liver disease Donghee Kim, Goh Eun Chung, Min-Sun Kwak, Yoon Jun Kim, Jung-Hwan Yoon Digestive and Liver Disease.2018; 50(4): 389. CrossRef
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction Goh Eun Chung, Jeong-Hoon Lee, Heesun Lee, Min Kyung Kim, Jeong Yoon Yim, Su-Yeon Choi, Yoon Jun Kim, Jung-Hwan Yoon, Donghee Kim Atherosclerosis.2018; 272: 137. CrossRef
Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population Goh Eun Chung, Young Lee, Jeong Yoon Yim, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Boram Park, Jong-Eun Lee, Jeong A Kim, Joo Sung Kim Gut and Liver.2018; 12(3): 316. CrossRef
Management of Patients with Nonalcoholic Fatty Liver Disease with Lifestyle Modification Byung-Wan Lee The Journal of Korean Diabetes.2018; 19(2): 82. CrossRef
Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease Hyekyung Yang, Cheol-Young Park The Journal of Korean Diabetes.2018; 19(2): 88. CrossRef
Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease Nissar U. Ashraf, Mohammad Altaf Mutation Research/Reviews in Mutation Research.2018; 778: 1. CrossRef
Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States Seung Joo Kang, Hwa Jung Kim, Donghee Kim, Aijaz Ahmed, Silvia C. Sookoian PLOS ONE.2018; 13(8): e0202325. CrossRef
Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim Digestive and Liver Disease.2017; 49(1): 57. CrossRef
Epigenetics in non-alcoholic fatty liver disease Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi Molecular Aspects of Medicine.2017; 54: 78. CrossRef
Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia J. S. Ahn, D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S.‐H. Jung, S. Gu, P.‐L. Rhee, S. W. Paik, H. J. Son, G.‐Y. Gwak Alimentary Pharmacology & Therapeutics.2017; 45(2): 345. CrossRef
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Joo Sung Kim Liver International.2017; 37(6): 919. CrossRef
Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Seonhye Gu, Hyunkyoung Kim, Donghyeong Seong, Soo Jin Cho, Byoung-Kee Yi, Hyung-Doo Park, Seung Woon Paik, Young Bin Song, Mariana Lazo, Joao A C Lima, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak Gut.2017; 66(2): 323. CrossRef
Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma Jee San Lee, Jeong Eun Yoo, Haeryoung Kim, Hyungjin Rhee, Myoung Ju Koh, Ji Hae Nahm, Jin Sub Choi, Kee-Ho Lee, Young Nyun Park, Olorunseun Ogunwobi PLOS ONE.2017; 12(3): e0171922. CrossRef
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease Tae Jun Kim, Dong Hyun Sinn, Yang Won Min, Hee Jung Son, Jae J. Kim, Yoosoo Chang, Sun-Young Baek, Soo Hyun Ahn, Hyuk Lee, Seungho Ryu Journal of Gastroenterology.2017; 52(11): 1201. CrossRef
Radiologic Evaluation of Non-Alcoholic Fatty Liver Disease in Diabetic Patient Kwang Joon Kim, Seung Up Kim, Yong Eun Chung, Chang Oh Kim The Journal of Korean Diabetes.2017; 18(2): 88. CrossRef
Non-alcoholic Fatty Liver Disease: A Clinical Update Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran Journal of Clinical and Translational Hepatology.2017; XX(XX): XX. CrossRef
Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data Yong-ho Lee The Journal of Korean Diabetes.2017; 18(2): 102. CrossRef
Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study Dong Hyun Sinn, Danbee Kang, Hye Ryoun Jang, Seonhye Gu, Soo Jin Cho, Seung Woon Paik, Seungho Ryu, Yoosoo Chang, Mariana Lazo, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak Journal of Hepatology.2017; 67(6): 1274. CrossRef
Effects of Kamichunggantang on Lipoapoptosis and inflammation of NAFLD in db/db mice Soo young Kwon, Kang-Hoon Kim, Yumi Kim, In-Seung Lee, Ji Young Park, Hyeon-Soo jeong, Jang-Hoon Lee, Hyeung-Jin Jang Oriental Pharmacy and Experimental Medicine.2017; 17(4): 365. CrossRef
Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence Jie Ting Tang, Yi Min Mao Journal of Digestive Diseases.2017; 18(11): 607. CrossRef
Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han Digestive Diseases and Sciences.2017; 62(8): 2150. CrossRef
Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men Hae Jin Yang, Sang Goon Shim, Bong Oh Ma, Ji Yeong Kwak European Journal of Gastroenterology & Hepatology.2016; 28(3): 338. CrossRef
Discordance between conventional ultrasonography and ElastPQ for assessing hepatic fibrosis in chronic hepatitis B: frequency and independent factors Mi Sung Kim, Byung Ik Kim, Heon-Ju Kwon, Hae Won Park, Hee-Jin Park, Ki Bae Bang, Hyun Pyo Hong, Myung Ho Rho Journal of Medical Ultrasonics.2016; 43(2): 201. CrossRef
Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis Dong Hyun Sinn, Soo Jin Cho, Geum-Youn Gwak, Juhee Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik Medicine.2016; 95(3): e2578. CrossRef
Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease Meegun Hong, Yoon Hyeong Lee, Seungwoo Kim, Ki Tae Suk, Chang Seok Bang, Jai Hoon Yoon, Gwang Ho Baik, Dong Joon Kim, Myong Jo Kim Journal of Ginseng Research.2016; 40(3): 203. CrossRef
Can Pharmacologic Therapy Induce Histologic Improvement in Non-alcoholic Steatohepatitis? Nae-Yun Heo The Korean Journal of Gastroenterology.2016; 67(5): 286. CrossRef
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis Dong Hyun Sinn, Soo Jin Cho, Seonhye Gu, Donghyeong Seong, Danbee Kang, Hyunkyoung Kim, Byoung-Kee Yi, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak Gastroenterology.2016; 151(3): 481. CrossRef
Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease Bong Jin Ko, Young Seok Kim, Sang Gyune Kim, Jung Hwan Park, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim, Sun Mi Kim, Young Don Kim, Gab Jin Cheon, Bo Ra Lee Gut and Liver.2016; 10(5): 818. CrossRef
Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim Gastroenterology Research and Practice.2016; 2016: 1. CrossRef
Clinical guidelines of non-alcoholic fatty liver disease: A systematic review Jin-Zhou Zhu, Kelseanna Hollis-Hansen, Xing-Yong Wan, Su-Juan Fei, Xun-Lei Pang, Fan-Dong Meng, Chao-Hui Yu, You-Ming Li World Journal of Gastroenterology.2016; 22(36): 8226. CrossRef
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim Clinical and Molecular Hepatology.2015; 21(4): 379. CrossRef
The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Seon Hee Lim, Jong In Yang, Young Sun Kim, Sun Young Yang, Min-Sun Kwak, Joo Sung Kim, Sang-Heon Cho BioMed Research International.2015; 2015: 1. CrossRef
Hepatic fat, not visceral fat, is associated with gallbladder polyps: A study of 2643 healthy subjects Seon Hee Lim, Donghee Kim, Jin Hwa Kang, Ji Hyun Song, Sun Young Yang, Jeong Yun Yim, Su Jin Chung, Joo Sung Kim, Sang‐Heon Cho Journal of Gastroenterology and Hepatology.2015; 30(4): 767. CrossRef
Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease Goh Eun Chung, Donghee Kim, Min Sun Kwark, Won Kim, Jeong Yoon Yim, Yoon Jun Kim, Jung-Hwan Yoon Medicine.2015; 94(9): e573. CrossRef
Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index Goh Eun Chung, Su-Yeon Choi, Donghee Kim, Min-Sun Kwak, Hyo Eun Park, Min-Kyung Kim, Jeong Yoon Yim Medicine.2015; 94(12): e654. CrossRef
Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Su Jong Yu, Won Kim, Donghee Kim, Jung-Hwan Yoon, Kyoungbun Lee, Jung Ho Kim, Eun Ju Cho, Jeong-Hoon Lee, Hwi Young Kim, Yoon Jun Kim, Chung Yong Kim Medicine.2015; 94(48): e2159. CrossRef
Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kim, Yoon Jun Kim, Jung‐Hwan Yoon Liver International.2015; 35(3): 944. CrossRef
Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population Min-Sun Kwak World Journal of Gastroenterology.2015; 21(20): 6287. CrossRef
Management of Non-alcoholic Fatty Liver Disease Jaechan Leem, Eun Hee Koh The Journal of Korean Diabetes.2014; 15(2): 93. CrossRef
Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition Joo Lee, Simonetta Friso, Sang-Woon Choi Nutrients.2014; 6(8): 3303. CrossRef
The Diagnosis of Nonalcoholic Fatty Liver Disease Moon Young Kim Korean Journal of Medicine.2014; 86(4): 405. CrossRef
Clinical Correlation between Serum Cytokeratin-18 and Metabolic Parameters in Patients with Sonographic Non-alcoholic Fatty Liver Disease Dong Shin Kwak, Dae Won Jun, Yong Kyun Cho, Seung Min Lee, Se Hwan Lee, In Sub Jung, Sung Won Lee, Jae Keun Park, JungHoon Lee, Eun Young Lee, Min Rho, Kang Lok Lee, Jun Kwon Ko, Soon-Eung Park The Korean Journal of Gastroenterology.2014; 64(4): 206. CrossRef
Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease Sang Hoon Park Korean Journal of Medicine.2014; 86(4): 425. CrossRef
Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: The role of interdisciplinary therapy Priscila L. Sanches, Aline de Piano, Raquel M.S. Campos, June Carnier, Marco T. de Mello, Natália Elias, Francisco A.H. Fonseca, Deborah C.L. Masquio, Patrícia L. da Silva, Flavia C. Corgosinho, Lian Tock, Lila M. Oyama, Sergio Tufik, Ana R. Dâmaso Journal of Clinical Lipidology.2014; 8(3): 265. CrossRef
Comparison on the Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid in Patients with Abnormal Alanine Aminotransferase: Multicenter, Double-blinded, Randomized, Active-controlled Clinical Trial Sae Hwan Lee, Gab Jin Cheon, Hong Soo Kim, Young Don Kim, Sang Gyune Kim, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim The Korean Journal of Gastroenterology.2014; 64(1): 31. CrossRef
Nonalcoholic Fatty Liver Disease: Lifestyle Modification Ki Deok Yoo, Dae Won Jun Korean Journal of Medicine.2014; 86(4): 416. CrossRef
First
Prev
